| Mitchell Binkley, MD | |
|
1345 W Central Park Ave, Davenport, IA 52804-1844 | |
| (563) 421-4455 | |
| Not Available |
| Full Name | Mitchell Binkley |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 7 Years |
| Location | 1345 W Central Park Ave, Davenport, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790215994 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | R-10991 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Genesis Vna | Bettendorf, IA | Home health agency |
| Kindred At Home | Rock island, IL | Home health agency |
| Genesis Hospice | Bettendorf, IA | Hospice |
| Genesis Hlth System Dba Genesis Mdl Ctr-illini | Silvis, IL | Hospital |
| Genesis Medical Center-davenport | Davenport, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Genesis Health System | 7214841436 | 184 |
News Archive
Chest X-rays may miss 40% of clinically significant thoracic injuries in multiple trauma patients that can be caught by chest CT, say researchers from Massachusetts General Hospital in Boston.
Scientists from Scripps Research Institute on Thursday announced they have discovered and isolated two antibodies "with the ability to neutralize [or block the action of] many strains of the AIDS virus, a discovery that might help create a long-sought vaccine against the deadly disease," Bloomberg reports.
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced the completion of its initial public offering of six million shares of common stock at a price of $7.00 per share. The net proceeds of the offering to Anthera, after deducting underwriting discounts and commissions and estimated offering expenses payable by Anthera, were approximately $36.7 million.
Researchers at the University of California, San Diego School of Medicine have found one of the keys to why certain glioblastomas - the primary form of a deadly brain cancer - are resistant to drug therapy.
Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today announced that it has purchased controlling interest, 50.1 percent, of Biocordcell Argentina S.A. (BioCells, Inc.).
› Verified 1 days ago
| Entity Name | Genesis Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477654945 PECOS PAC ID: 7214841436 Enrollment ID: O20031113000044 |
News Archive
Chest X-rays may miss 40% of clinically significant thoracic injuries in multiple trauma patients that can be caught by chest CT, say researchers from Massachusetts General Hospital in Boston.
Scientists from Scripps Research Institute on Thursday announced they have discovered and isolated two antibodies "with the ability to neutralize [or block the action of] many strains of the AIDS virus, a discovery that might help create a long-sought vaccine against the deadly disease," Bloomberg reports.
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced the completion of its initial public offering of six million shares of common stock at a price of $7.00 per share. The net proceeds of the offering to Anthera, after deducting underwriting discounts and commissions and estimated offering expenses payable by Anthera, were approximately $36.7 million.
Researchers at the University of California, San Diego School of Medicine have found one of the keys to why certain glioblastomas - the primary form of a deadly brain cancer - are resistant to drug therapy.
Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today announced that it has purchased controlling interest, 50.1 percent, of Biocordcell Argentina S.A. (BioCells, Inc.).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mitchell Binkley, MD 1345 W Central Park Ave, Davenport, IA 52804-1844 Ph: () - | Mitchell Binkley, MD 1345 W Central Park Ave, Davenport, IA 52804-1844 Ph: (563) 421-4455 |
News Archive
Chest X-rays may miss 40% of clinically significant thoracic injuries in multiple trauma patients that can be caught by chest CT, say researchers from Massachusetts General Hospital in Boston.
Scientists from Scripps Research Institute on Thursday announced they have discovered and isolated two antibodies "with the ability to neutralize [or block the action of] many strains of the AIDS virus, a discovery that might help create a long-sought vaccine against the deadly disease," Bloomberg reports.
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced the completion of its initial public offering of six million shares of common stock at a price of $7.00 per share. The net proceeds of the offering to Anthera, after deducting underwriting discounts and commissions and estimated offering expenses payable by Anthera, were approximately $36.7 million.
Researchers at the University of California, San Diego School of Medicine have found one of the keys to why certain glioblastomas - the primary form of a deadly brain cancer - are resistant to drug therapy.
Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today announced that it has purchased controlling interest, 50.1 percent, of Biocordcell Argentina S.A. (BioCells, Inc.).
› Verified 1 days ago
Dr. Bryant A. Mutchler, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3200 W Kimberly Rd Ste 200, Davenport, IA 52806 Phone: 563-421-0268 Fax: 563-421-0269 | |
Dr. Jesicah Elisabeth Ambrisco, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1345 W Central Park Ave, Davenport, IA 52804 Phone: 563-421-4400 Fax: 563-421-4449 | |
Nicholas Nicchitta, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1345 W Central Park Ave, Davenport, IA 52804 Phone: 563-421-4400 | |
Thang Luong, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1345 W Central Park Ave, Davenport, IA 52804 Phone: 563-421-4400 Fax: 563-421-4449 | |
Mohsin Ali Khan, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1111 W Kimberly Rd, Davenport, IA 52806 Phone: 563-650-6825 | |
Joshua Carpenter, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1345 W Central Park Ave, Davenport, IA 52804 Phone: 563-421-4400 Fax: 563-421-4449 | |
Dr. Tammy Jo Wells, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1820 E 54th St, Suite B, Davenport, IA 52807 Phone: 563-355-9990 Fax: 563-355-9999 |